Shares outstanding · 2011–2025
Neogenomics shares outstanding
130M+1.1% · FY2025
Neogenomics (NEO) reported 130M in shares outstanding for fiscal 2025, +1.1% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252026-02-13 | 130M | +1.1% | Open → |
| FY20242025-02-11 | 128M | +0.7% | Open → |
| FY20232024-02-13 | 128M | +0.5% | Open → |
| FY20222022-12-31 | 127M | +2.3% | Open → |
| FY20212021-12-31 | 124M | +10.7% | Open → |
| FY20202020-12-31 | 112M | +7.0% | Open → |
| FY20192019-12-31 | 105M | +10.9% | Open → |
| FY20182018-12-31 | 94.5M | +17.4% | Open → |
| FY20172017-12-31 | 80.5M | +2.4% | Open → |
| FY20162016-12-31 | 78.6M | +3.6% | Open → |
| FY20152015-12-31 | 75.8M | +25.9% | Open → |
| FY20142014-12-31 | 60.2M | +22.6% | Open → |
| FY20132013-12-31 | 49.1M | +8.5% | Open → |
| FY20122012-12-31 | 45.3M | +4.3% | Open → |
| FY20112011-12-31 | 43.4M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +8.1%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Neogenomics shares outstanding |url=https://companiesranked.com/en/company/neogenomics/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Neogenomics shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/neogenomics/shares-outstandingBibTeX
@misc{companiesranked-en-company-neogenomics-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Neogenomics shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/neogenomics/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001077183-26-000010 · February 17, 2026
{{cite web |title=Neogenomics shares outstanding — 10-K (0001077183-26-000010) |url=https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.